Terms: = Colorectal cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Treatment
22 results:
1. Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi receptor approach for potential therapeutic agents in colorectal cancer.
Stany B; Mishra S; Rao KVB
Med Oncol; 2024 May; 41(6):156. PubMed ID: 38750377
[TBL] [Abstract] [Full Text] [Related]
2. Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis.
Jiang Y; Zhao M; Tang W; Zheng X
BMC Cancer; 2024 Feb; 24(1):188. PubMed ID: 38336718
[TBL] [Abstract] [Full Text] [Related]
3. Decision aids for people facing health treatment or screening decisions.
Stacey D; Lewis KB; Smith M; Carley M; Volk R; Douglas EE; Pacheco-Brousseau L; Finderup J; Gunderson J; Barry MJ; Bennett CL; Bravo P; Steffensen K; Gogovor A; Graham ID; Kelly SE; Légaré F; Sondergaard H; Thomson R; Trenaman L; Trevena L
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD001431. PubMed ID: 38284415
[TBL] [Abstract] [Full Text] [Related]
4. Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach.
Gordon S; Chan DLH; Bernard EJ; Eslick ME; Willowson KP; Roach PJ; Engel AF; Maher R; Clarke SJ; Agarwal V; Yasmin L; De Silva M; Mascall S; Conner A; Nevell D; Pavlakis N; Bailey DL
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7717-7728. PubMed ID: 37004598
[TBL] [Abstract] [Full Text] [Related]
5. Drug Repurposing and Systems Biology approaches of Enzastaurin can target potential biomarkers and critical pathways in colorectal cancer.
Somadder PD; Hossain MA; Ahsan A; Sultana T; Soikot SH; Rahman MM; Ibrahim SM; Ahmed K; Bui FM
Comput Biol Med; 2023 Mar; 155():106630. PubMed ID: 36774894
[TBL] [Abstract] [Full Text] [Related]
6. Establishment of the prediction model and biological mechanism exploration for secondary imatinib-resistant in gastrointestinal stromal tumor.
Wang C; Shen Z; Jiang K; Gao Z; Ye Y
Scand J Gastroenterol; 2022 Nov; 57(11):1334-1343. PubMed ID: 35723035
[TBL] [Abstract] [Full Text] [Related]
7. Post-Acute Care Outcomes and Functional Status Changes of Adults with New cancer Discharged to Skilled Nursing Facilities.
Singh S; Molina E; Meyer E; Min SJ; Fischer S
J Am Med Dir Assoc; 2022 Nov; 23(11):1854-1860. PubMed ID: 35337793
[TBL] [Abstract] [Full Text] [Related]
8. Targeting UNC-51-like kinase 1 and 2 by lignans to modulate autophagy: possible implications in metastatic colorectal cancer.
Sain A; Kandasamy T; Naskar D
Mol Divers; 2023 Feb; 27(1):27-43. PubMed ID: 35192112
[TBL] [Abstract] [Full Text] [Related]
9. [Therapy-Related Acute Myeloid Leukemia with 11q23 Abnormality That Developed after Chemotherapy for colorectal cancer].
Saito M; Miyajima T; Ogasawara R; Yokoyama E; Izumiyama K; Mori A; Morioka M; Kondo T
Gan To Kagaku Ryoho; 2021 Jul; 48(7):971-974. PubMed ID: 34267039
[TBL] [Abstract] [Full Text] [Related]
10. Systematic review: the effect of right hemicolectomy for cancer on postoperative bowel function.
Hope C; Reilly J; Lund J; Andreyev H
Support Care Cancer; 2020 Oct; 28(10):4549-4559. PubMed ID: 32430603
[TBL] [Abstract] [Full Text] [Related]
11. Physical activity interventions for disease-related physical and mental health during and following treatment in people with non-advanced colorectal cancer.
McGettigan M; Cardwell CR; Cantwell MM; Tully MA
Cochrane Database Syst Rev; 2020 May; 5(5):CD012864. PubMed ID: 32361988
[TBL] [Abstract] [Full Text] [Related]
12. Transanal drainage tubes vs metallic stents for acute malignant left-sided bowel obstruction: A systematic review and meta-analysis.
Xu J; Zhang S; Jiang T; Zhao YJ
Medicine (Baltimore); 2020 Jan; 99(2):e18623. PubMed ID: 31914042
[TBL] [Abstract] [Full Text] [Related]
13. Coexistence of colon adenocarcinoma, diffuse large B-cell lymphoma, and myelodysplastic syndrome: A case report.
Wang W; Li P
Medicine (Baltimore); 2019 Aug; 98(35):e16742. PubMed ID: 31464903
[TBL] [Abstract] [Full Text] [Related]
14. Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN).
Kong G; Grozinsky-Glasberg S; Hofman MS; Akhurst T; Meirovitz A; Maimon O; Krausz Y; Godefroy J; Michael M; Gross DJ; Hicks RJ
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):718-727. PubMed ID: 30343432
[TBL] [Abstract] [Full Text] [Related]
15. [Azacitidine for Therapy-Related Myelodysplastic Syndrome Following Oxaliplatin (L-OHP)Therapy for Metastatic Rectal cancer].
Matsui T; Sakamoto N; Doi A; Fujii T; Ohno N; Sahara N; Irie S
Gan To Kagaku Ryoho; 2018 Aug; 45(8):1201-1203. PubMed ID: 30158420
[TBL] [Abstract] [Full Text] [Related]
16. Long-term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
[TBL] [Abstract] [Full Text] [Related]
17. Radiotherapy- and chemotherapy-induced myelodysplasia syndrome: a nationwide population-based nested case-control study.
Sun LM; Lin CL; Lin MC; Liang JA; Kao CH
Medicine (Baltimore); 2015 May; 94(17):e737. PubMed ID: 25929909
[TBL] [Abstract] [Full Text] [Related]
18. Comparative proteomic analysis of colon cancer cell HCT-15 in response to all-trans retinoic acid treatment.
Zhao J; Wen G; Ding M; Pan JY; Yu ML; Zhao F; Weng XL; Du JL
Protein Pept Lett; 2012 Dec; 19(12):1272-80. PubMed ID: 22670670
[TBL] [Abstract] [Full Text] [Related]
19. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract] [Full Text] [Related]
20. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
Galustian C; Meyer B; Labarthe MC; Dredge K; Klaschka D; Henry J; Todryk S; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB; Dalgleish AG
Cancer Immunol Immunother; 2009 Jul; 58(7):1033-45. PubMed ID: 19009291
[TBL] [Abstract] [Full Text] [Related]
[Next]
